Aquestive furnishes Sept 23, 2026 investor presentation; 8-K text contains no operational or financial detail

Aquestive Therapeutics, Inc.

Exhibit 99.1 is titled 'Corporate Presentation' dated September 23, 2026; the appended exhibit text contains only the standard forward-looking-statement disclaimer.
No revenue, EPS, guidance, clinical-trial or partnership data appears anywhere in the filing or the exhibit text provided.
Event date listed as September 23, 2026; the 8-K is dated and signed September 25, 2026 by CFO A. Ernest Toth, Jr.
Company says the deck is available on the Events and Presentations page of the Investors section at www.aquestive.com; content was not reproduced in the filing.
Cannot summarize substantive news because Exhibit 99.1's body was not included beyond the disclaimer.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.